|
NVNO Envveno Medical Corp 1661053 |
| Income Statement |
|
Net Income
|
form10-k
|
-21,819,000 |
| Balance Sheet |
|
Current Assets
|
43,734,000 |
|
Assets
|
44,954,000 |
|
Current Liabilities
|
2,095,000 |
|
Liabilities
|
2,795,000 |
|
Equity
|
42,159,000 |
|
Shares Out
|
13,330,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-16,838,000 |
|
Investing Cash Flow
|
1,335,000 |
| Market Analysis |
Market Cap
|
71,674,079 |
|
Price
|
2.89 |
|
BVPS
|
3.16 |
|
PB
|
0.93 |
|
EPS
|
-1.43 |
|
PS
|
22.35 |
|
FCF
|
-15,503,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NVNO documents filed with the SEC.
NVNO Filings
Clear
